GSK-led Team Develops Mass Spec Thermal Profiling Method for Studying Protein-Drug Interactions
NEW YORK (GenomeWeb) – A team led by researchers at Cellzome, a part of GlaxoSmithKline's R&D division, has developed a thermal profiling-based method for identifying protein drug targets and measuring protein-drug binding.
While chemical proteomics has traditionally focused on pharmaceutical work, several recent collaborations suggest that the field is establishing a foothold within agricultural research, as well.
This article originally ran on May 15 and has been updated to include additional comments from GlaxoSmithKline. GlaxoSmithKline said today that it has entered an agreement to purchase chemical proteomics firm Cellzome for £61 million ($99 million).
GlaxoSmithKline to Acquire Cellzome for $99M
NEW YORK (GenomeWeb News) – GlaxoSmithKline today said that it has reached an agreement to acquire the remaining 80 percent of proteomics firm Cellzome that it didn't already own for £61 million ($99 million).
A research team led by scientists at proteomics firm Cellzome has developed a selective inhibitor to the PI3 kinase isoform PI3Kγ.
Dec 9, 2011
Sep 16, 2011
Feb 25, 2011
Movers & Shakers: Feb 25, 2011
Feb 11, 2011
Mar 10, 2010